Atossa Therapeutics
ATOS
#9776
Rank
ยฃ32.62 M
Marketcap
ยฃ3.79
Share price
-0.79%
Change (1 day)
611.53%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: ยฃ32.62 Million

As of March 2026 Atossa Therapeutics has a market cap of ยฃ32.62 Million. This makes Atossa Therapeutics the world's 9776th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ32.62 M-48.38%
2025ยฃ63.19 M-35.74%
2024ยฃ98.35 M13.63%
2023ยฃ86.55 M56.47%
2022ยฃ55.31 M-63.15%
2021ยฃ0.15 B352.91%
2020ยฃ33.13 M203.13%
2019ยฃ10.93 M132.7%
2018ยฃ4.69 M-24.14%
2017ยฃ6.19 M43.06%
2016ยฃ4.32 M-38.62%
2015ยฃ7.05 M-68.74%
2014ยฃ22.56 M-13.64%
2013ยฃ26.12 M-16.2%
2012ยฃ31.17 M

End of Day market cap according to different sources

On Mar 13th, 2026 the market cap of Atossa Therapeutics was reported to be:

ยฃ32.62 Million
by Nasdaq info icon info icon
ยฃ32.62 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ440.15 B 1,348,984.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ16.79 B 51,391.47%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ16.53 B 50,589.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ2.13 B 6,445.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ0.77 B 2,270.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ27.66 M-15.19%๐Ÿ‡บ๐Ÿ‡ธ USA